Abstract: Mitral regurgitation after a myocardial infarction is common. It can occur acutely or chronically, and its presence portends a poor prognosis. The focus of this article will be on chronic ischemic mitral regurgitation. We will discuss the current concepts of its pathophysiology, the benefits of revascularization, along with the surgical, and percutaneous therapeutic options.
A pproximately 50% to 60% of patients with congestive heart failure have some degree of mitral regurgitation (MR), and in 30% of these, the MR is moderate or severe. 1 The majority of these individuals have a structurally normal mitral valve (MV), but the valve is incompetent because of left ventricular remodeling that has disturbed the relationship between the subvalvular apparatus and the MV leaflets. This type of MR is referred to as functional MR. Functional MR in the subgroup of patients in which the underlying ventricular remodeling is due to a myocardial infarction (MI), is referred to as ischemic MR. The presence of MR after an MI is associated with a worse prognosis. 2 In those with 3ϩ to 4ϩ MR, the 5-year survival is approximately 50%, even with surgical intervention. 3 
DEFINITION, CLASSIFICATION, AND PATHOPHYSIOLOGY OF CHRONIC ISCHEMIC MITRAL REGURGITATION
Ischemic MR is defined as MR complicating the manifestations of coronary artery disease in the absence of primary leaflet, or chordal pathology. 4 Any disruption of the proper function of the mitral annulus, the valve leaflets, the chordae tendineae, the papillary muscles, or the supporting left ventricular walls may lead to MR. Carpentier developed a functional classification to describe the lesions responsible for MR 5 based on the motion of the MV leaflets ( Fig. 1) . 6 In this classification, type I dysfunction is characterized by normal leaflet motion, with the MR being caused by annular dilatation or leaflet perforation; type II dysfunction is caused by an increased leaflet motion such as with leaflet prolapse, chordal rupture, or papillary muscle rupture; type IIIa has restricted leaflet motion during both diastole and systole, caused by subvalvular fibrosis, and commissural fusion, as seen in patients with rheumatic heart disease; type IIIb dysfunction has restricted leaflet motion during systole, and is due to left ventricular enlargement and papillary muscle displacement. This is the most common lesion associated with chronic ischemic MR.
The cause of MR in ischemic MR is due to (1) mitral annular dilatation, and/or (2) papillary muscle displacement. This process causes (1) leaflet malcoaptation, which is the failure of the leaflets to meet, and (2) malapposition, which is the failure of the leaflets to close at the same plane. Although mitral annular dilatation has been described as a cause of MR, it has been shown that isolated annular dilatation, per se, does not cause significant regurgitation. 7 In only 5% of the cases of ischemic MR does annular dilatation play a significant role. 6 This means that the predominant cause of ischemic MR is the apical and lateral displacement of the papillary muscles, leading to tethering of the MV leaflets, with subsequent decreased coaptation. 8 This tethering of the leaflets is more commonly seen after a posteroinferior than an anterolateral wall MI. 9 Therefore, it is more common for the posteromedial papillary muscle to be the culprit associated with ischemic MR, and it affects mainly the P3/P2 segment of the posterior leaflet 6 ( Fig. 2 ).
CORONARY ARTERY REVASCULARIZATION
Since the underlying cause of ischemic MR is coronary artery disease, it would seem intuitive that coronary artery revascularization would ameliorate the severity of the MR. However, the data show that in most patients coronary artery revascularization does not correct the MR. A study of 136 patients 10 with ischemic MR who underwent isolated coronary artery bypass graft surgery (CABG) showed on postoperative transthoracic echocardiogram that 40% of patients were left with 3 to 4ϩ MR, and 51% were left with 2ϩ MR. Only 9% of patients had significant improvement, with no more than trace (0 to 1ϩ) MR. Another report of 92 patients with 3ϩ to 4ϩ ischemic MR undergoing isolated CABG showed that in postoperative echocardiographic follow-up, nearly half the patients still had 3ϩ to 4ϩ MR.
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CABG VERSUS CABG AND MV REPAIR
To date, no randomized trial has been done to evaluate the efficacy of MV repair when performed at the time of CABG. The published data have all been retrospective analyses. Wu et al 12 evaluated 682 patients with moderate to severe MR and ejection fraction Ͻ30% who underwent CABG; 419 patients underwent CABG alone, and 126 underwent CABG with MV repair. When the CABG MV repair group was compared with the CABG group, there was no demonstrable mortality benefit conferred by the MV repair. Another study from the Cleveland Clinic 13 evaluated 390 patients with 3ϩ/4ϩ MR, with varying degrees of left ventricular systolic dysfunction. Of these, 290 patients underwent CABG with MV repair and were compared with 100 patients who underwent CABG alone. Their conclusions were that the addition of MV annuloplasty to CABG did not improve long-term functional status or survival. Similar studies have come to the same conclusions. 
MITRAL VALVE REPLACEMENT
Although no randomized trial has been performed comparing the benefits of MV replacement versus MV repair, it appears that MV repair has a lower operative mortality and a better long-term survival when compared with MV replacement.
14 However, MV replacement is still a reasonable option for patients with acute MR, and for those with chronic ischemic MR and multiple comorbidities, complex regurgitant jets (noncentral jet or more than one jet), or severe tethering of both MV leaflets. 15 When considering which type of valve to implant, it is important to take into account that the majority of patients do not survive much longer than 5 years. A bioprosthetic valve in the mitral position starts to deteriorate approximately 6 years postimplant. 16 As a result, some surgeons recommend the use of a bioprosthetic valve over a mechanical one, irrespective of the patient's age, to avoid chronic anticoagulation. 17 Also, chordal preservation is less technically demanding, and there are fewer potential postoperative valve-related complications if a bioprosthetic valve is used.
To evaluate the safety and efficacy of MV repair and MV replacement for patients with severe ischemic MR, a multicenter randomized trial titled "Evaluation of Outcomes Following Mitral Valve Repair/Replacement in Severe Chronic Ischemic Mitral Regurgitation"
18 is now taking place. Patients will be randomized to MV repair with annuloplasty and a subvalvular procedure for severe tethering, or to MV replacement with complete preservation of the subvalvular apparatus. The primary end point of the study is the degree of left ventricular remodeling at 12 months.
MITRAL VALVE REPAIR
The most common type of surgery performed for ischemic MR is an undersized mitral annuloplasty. In this technique, a small (size 24 to 26 mm) mitral annuloplasty ring is used 19 which causes a reduction in the anteroposterior (septolateral) diameter of the MV increasing the surface of coaptation. The procedure is fairly easy to perform and reproducible. Over the past few years, many different types of prosthetic rings have been developed, some are flexible, others rigid, some are complete, others incomplete. However, there are no definite data that show that one ring is superior to another.
The drawback with the undersized annuloplasty technique is the high rate of failure. In an article from Cleveland Clinic, 585 patients who had undersized annuloplasty surgery over a 17-year period were examined. 20 In 28% of the patients, moderate or more MR developed 6 months postoperatively. It is felt that the reason for the recurrent MR is that the underlying process of left ventricular dilatation from left ventricular remodeling continues despite having "fixed" the valve. This remodeling causes further tethering of the papillary muscles, especially the posteromedial papillary muscle, and causes the recurrence of MR. 21 One needs to bear in mind that ischemic MR is more a ventricular problem than a valvular one.
To address the issue of remodeling, the Carpentier-McCarthyAdams IMR ETlogix annuloplasty ring (CMA IMR ETlogix ring; Edwards Lifescience, Irvine, CA), was developed. This ring was designed with a reduced middle to medial (P2-P3) curvature, and a slight dip at the P3-P2 segments to increase coaptation of these tethered segments. Evaluation of this ring in 59 patients showed that after surgery 57 of 59 (97%) patients had grade 0 to 1ϩ MR, FIGURE 1. Carpentier's functional classification of mitral regurgitation. Type I is characterized by normal leaflet motion, with the mitral regurgitation being caused by annular dilatation or leaflet perforation; type II is caused by an increased leaflet motion such as leaflet prolapse, chordal rupture, or papillary muscle rupture; type IIIa has restricted leaflet motion caused by subvalvular fibrosis, and commissural fusion, as seen in patients with rheumatic heart disease; type IIIb dysfunction has restricted leaflet motion during systole, and is due to left ventricular enlargement and papillary muscle displacement. Reprinted with permission from Am Heart Hosp J. 2006;4:261-268. whereas 2 patients had 2ϩ MR. 22 This new prosthetic ring may improve the durability of MV repair. However, long-term results are not yet available.
EDGE-TO-EDGE REPAIR
This technique, also known as the Alfieri stitch, involves placing a suture at the center (A2-P2 portion) of the margins of both leaflets, creating a double orifice MV. 23 An annuloplasty ring needs to be placed with this procedure, because of poor long-term results without it. 24 Even with an annuloplasty ring, the failure rate for this procedure is high. Bhudia et al performed the edge-to-edge repair with a flexible posterior annuloplasty band in 143 patients with ischemic cardiomyopathy. 25 At 2 years postoperatively, the proportion of patients with moderate MR (2ϩ) was 23%, and the moderately severe MR (3ϩ) was 24%. They concluded that other techniques were needed to correct the MR. Overall, the edge-to-edge repair has fallen out of favor, and is not frequently used.
ANTERIOR LEAFLET AUGMENTATION
A simple approach to the tethering of the MV leaflets was reported by Kincaid et al. 26 The anterior leaflet was augmented in size by creating a defect in it, in the shape of an ellipse. The defect was then filled with a piece of bovine pericardium, and a flexible 27-to 31-mm posterior annuloplasty band was placed. This method allowed the level of leaflet coaptation to fall more posteriorly, and towards the level of the displaced papillary muscles (Fig. 3) . This was performed in 25 patients with significant ischemic MR; postoperative transesophageal echocardiogram revealed trace or no MR in 80% of the patients and mild MR in 20%. At 2 years, the actuarial freedom from moderate or greater MR was 81%.
SECOND ORDER CHORDAL CUTTING
Another approach to reduce the tethering of the papillary muscles and chordae tendineae on the MV leaflets is by cutting the secondary cords. A study by Borger et al 27 compared 43 patients who underwent chordal-cutting MV repair to 49 patients having conventional MV repair. The procedure consisted of cutting all the secondary chords to the anterior leaflet, posterior leaflet, and the commissure that arose from the affected papillary muscle. The secondary chords arising from the normal papillary muscle were not divided. They also placed a moderately undersized (size 26 to 32 mm) flexible, incomplete annuloplasty band. The in-hospital mortality was 10% for the conventional annuloplasty group and 9% in the chordal cutting group. Their results showed that chordal cutting was associated with an improvement in the MV leaflet mobility, a reduction in MR recurrence, without reducing left ventricular function.
POSTERIOR MITRAL VALVE RESTORATION
Fundarò et al 28 developed a technique to reduce tethering of the MV leaflets and reduce the anteroposterior mitral annulus dimension after an inferior wall MI. Approaching the MV through a standard left atriotomy, an incision was made to detach the tethered segment of the posterior leaflet from the mitral annulus. Through this incision, the secondary chordae were transected to increase the mobility of the posterior leaflet. The detached portion of the mitral annulus was then plicated, and the resulting defect in the posterior leaflet was closed with a running suture. The plicated annulus was then reinforced with a Gore-Tex strip or posterior annuloplasty band (Fig. 4) . This technique was performed in 9 patients, and postoperative transesophageal echocardiogram showed mild or no MR in all patients.
PAPILLARY MUSCLE SLING
This procedure devised by Hvass et al involves placing a 4 mm Gore-tex tube through the left atrium and encircling the base of both papillary muscles. 29 The sling is tightened to decrease the distance between both papillary muscles, and a moderately undersized (30 mm) annuloplasty ring is placed (Fig. 5) . In their study of 10 patients, the tenting distance decreased from 14 to 4 mm, and the MR resolved in all the patients.
SURGICAL VENTRICULAR RESTORATION WITH PAPILLARY MUSCLE IMBRICATION
The term "surgical ventricular restoration" includes operative methods that reduce left ventricular volume and restore the ventricular elliptical shape. Its use is limited to anterior wall MIs. In this technique, the anteroseptal, apical, and anterolateral left ventricular scarred segments are excluded from the rest of the left ventricle with an intracardiac patch or by direct closure. 30 By altering the shape of the left ventricle and reducing wall stress, this procedure can reduce papillary muscle displacement and subsequent MR. 31 The RESTORE (Reconstructive Endoventricular Surgery returning Torsion Original Radius Elliptical shape to the left ventricle) study was an observational study of 1198 patients, with an anterior wall MI that underwent revascularization and surgical ventricular restoration. 32 A subgroup of 46 patients from this study also had an endoventricular MV repair without a prosthetic ring. 33 This was done through the left ventricle via the opening that was made for the surgical ventricular restoration procedure. A purse-string suture was placed that caused the papillary muscles to be brought closer together, or imbricated. Postoperatively, 84% of the patients had mild or less MR. The global operative mortality rate was 15.2%, and the cumulative survival at 30 months was 63%.
SURGICAL RELOCATION OF THE POSTERIOR PAPILLARY MUSCLE
Kron et al used a technique to reposition the displaced papillary muscles in 18 patients who had suffered a transmural inferior wall MI. 34 In patients whose LV end-systolic dimension was Ͻ6 cm, a 3-0 Prolene suture was passed twice through the fibrous portion of the posterior papillary muscle tip. The suture was then passed up through the adjacent mitral annulus just posterior to the right fibrous trigone. MV annuloplasty was then performed by placing a 26 to 28 mm annuloplasty ring (Fig. 6) . In patients whose left ventricular end-systolic dimension was Ͼ6 cm, a surgical ventricular restoration procedure was added. In these, surgical relocation of the posterior papillary muscle tip was performed through the left ventricle. At 8 weeks postoperative, 3 patients had trace MR, and the rest had no MR.
INFARCT PLICATION
This procedure is used exclusively in individuals with an inferolateral wall MI. It involves plicating the infarcted region without excision or cardiopulmonary bypass. This shortens the infarcted area, and brings the displaced papillary muscle back towards the mitral annulus, increasing the zone of coaptation, thus reducing the MR. Ramadan et al 35 used this approach in 3 patients. They placed mattressed sutures over the infarcted region with a Teflon patch. No annuloplasty ring was placed and no bypass was performed to the affected region (Fig. 7) . At 7 months, 2 had no MR, and the third had trivial MR.
INTEGRATED OVERLAPPING VENTRICULOPLASTY COMBINED WITH PAPILLARY MUSCLE PLICATION
In an attempt to reduce left ventricular wall stress and MR, Matsui et al combined an overlapping cardiac volume reduction operation with papillary muscle plication. 36 They took 8 patients with 3 to 4ϩ MR, in New York Heart Association functional class III-IV, and ejection fraction of 22%. MV annuloplasty with an undersized ring was performed. A 10-cm long incision was then made along the left anterior descending coronary artery. Through the incision, 3 pericardium-pledgeted mattress sutures were placed around the bases of the anterior and posterior papillary muscles, and were brought together. The left ventricle was then reduced in size by having the left marginal incision overlap the right marginal incision (Fig. 8) .
Of the 8 patients, 1 patient died 2 months after the operation due to irreversible cerebral damage. The other 7 were followed for 102 Ϯ 26 days. The New York Heart Association functional class was class I in 6 of the patients and class II in 1 patient. No MR was noted in the latest echocardiogram performed postoperatively. 
MITRAL COMPLEX REMODELING
This operation takes a slightly more comprehensive approach to the problems with ischemic MR, in that it addresses the valvular issues as well as the subvalvular ones. The procedure consists of division and reconstruction of secondary chords, undersized MV annuloplasty, and bilateral papillary muscle relocation. 37 In this technique, the secondary chords to the anterior leaflet from both papillary muscles are separated. Two pairs of 5-0 and 4 -0 Gore-Tex sutures are then placed through both fibrous portions of the anterior and posterior papillary muscle tips. Two pairs of the 5-0 sutures are passed through the middle portion of the anterior leaflet. The suture length is adjusted to be the same length as the marginal chords. This relieves the tethering of the anterior leaflet, and increases leaflet mobility. Each pair of the 4 -0 Gore-Tex sutures are then passed through the posterior annulus at sites around the border of the lateral and middle portions and middle and medial portion of the annulus, and are also passed through corresponding sites of a 26-mm semirigid annuloplasty ring. These annulopapillary sutures are then pulled to bring the papillary muscle tips closer to the annulus, so that the point of leaflet coaptation occurs in the plane of the mitral annulus during systole (Fig. 9) . This surgery was performed in 3 patients with severely reduced ejection fraction, and at mean 6 months follow-up, no or trivial MR was noted.
EXTERNAL COMPRESSION DEVICES
An innovative strategy to reverse remodeling has been the development of constraint devices. These devices are intended to improve left ventricular function by reducing wall stress, and provide passive diastolic support. The Acorn Corcap cardiac support device is a biocompatible mesh-like jacket that slips around the heart during surgery. It was evaluated in the ACORN trial, which was an unblinded trial that randomized 300 patients to 2 treatment arms depending on a need for MV surgery or only medical treatment, with or without use of the support device. In the subgroup of 193 patients who were enrolled in the MV repair/replacement stratum, 102 patients were randomized to the MV surgery alone group (control), and 91 were randomized to the MV surgery with implantation of the support device. 38 At 23 months median follow-up, the addition of the support device led to greater decreases in left ventricular volumes, a more elliptical left ventricle shape, a trend for reduction in major cardiac procedures, and improvement in quality of life compared with MV surgery alone.
PERCUTANEOUS PROCEDURES
The percutaneous approach for the treatment of MR is in its early stages of development. One approach to reduce the mitral annulus septal-lateral distance is to place a nitinol device in the coronary sinus. The CARILLON Mitral Annuloplasty Device European Union Study (AMADEUS) study showed that at 6 months, the device reduced MR by 23% and improved quality of life and exercise tolerance. 39 Another technique uses a trans-septal approach to perform an edge-to-edge mitral valve repair by placing a clip in the center of the mitral orifice. This was evaluated in the Endovascular Valve Edgeto-Edge Repair Studies (EVEREST I and II). 40 A total of 107 patients with 3ϩ to 4ϩ MR were treated. Acute procedural success was achieved in 79 of 107 (74%) patients, and 51 (64%) were discharged with MR of Յ1ϩ. Thirty-two patients (30%) had mitral valve surgery during the 3.2 years after the clip procedure. A total of 50 of 76 (66%) successfully-treated patients were free from death, mitral valve surgery, or MR Ͼ2ϩ at 12 months. Kaplan-Meier freedom from death was 95.9%, 94.0%, and 90.1%, and KaplanMeier freedom from surgery was 88.5%, 83.2%, and 76.3% at 1, 2, and 3 years, respectively. The 23 patients with functional MR had similar acute results and durability.
Percutaneous devices do not reduce the amount of MR to the extent that a surgical procedure would, however, because of their less invasive nature, these devices will most likely be reserved for patients deemed too high risk for surgery. 
